How can a private equity deal team run a competitor analysis during deal screening?
What to answer in the first pass
- Who does the target compete with according to buyers' search results and review categories, not only the confidential information memorandum?
- How do its prices compare with those competitors, plan for plan?
- Do competitors make the same promises on their homepages, or does the target own a position?
- What have competitors changed recently: prices, plans, launches, hiring?
- Which claims in the memorandum could not be confirmed from public pages?
Why public evidence first
A management presentation describes the market the seller wants you to see. Competitors' own pages show the market a buyer sees. Where the two disagree, you have your diligence questions, before you pay for a full commercial due diligence.
What it does not replace
Public pages do not show win rates, churn, pipeline or customer satisfaction. Those come from the data room, customer calls and a commercial due diligence provider. The public read tells you where to point that work.
How GTM Brain does it
A company report on the target shows what it sells, to whom and at what price, with a quote behind each line and suggested competitors. Pricing comparison and message comparison put the target next to up to five competitors, one table each. Reports can be shared as read-only links or downloaded for the deal team.
From the product

A company report run on 2 November 2026 on a public example, ChatGPT, not a deal target: the summary, business model and buyer hypotheses and published pricing, the same format a deal team gets for a target.
Run a company reportOther questions
What is an indication of interest?
A non-binding letter in which a buyer states its interest in acquiring a company and a value range, usually before full diligence. It comes before the letter of intent.
Can public evidence replace commercial due diligence?
No. It covers the competitive and pricing picture well, but not customers, churn or pipeline. Use it to focus commercial due diligence, not to skip it.